{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fidpodcast.simplecast.com%2Fepisodes%2Findividualizing-hiv-art-rapid-start-B6EqNFCt","width":444,"version":"1.0","type":"rich","title":"Individualizing HIV ART: Rapid Start","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/26d7523c-7315-48a0-9da6-29d252d3ce90/dd37c359-f228-4272-be9e-4ec2e9a8cf39/cmoh-dn-prp5074-pod-3-3000x3000.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/d35a35b9-08f9-4c29-b946-759c5674eb27\" height=\"200\" width=\"100%\" title=\"Individualizing HIV ART: Rapid Start\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Listen to Daniel R. Kuritzkes, MD, discuss considerations for rapid start of antiretroviral therapy in patients newly diagnosed with HIV, including management of patients with a history of receiving PrEP."}